Because NAT2 is involved in the metabolism of carcinogenic compounds, individuals with reduced NAT2 metabolism may have an increased risk of certain cancers, such as bladder cancer16 and lung cancer,17, 18 but these risks are dependent upon the extent of carcinogen exposure. The gene discussed is NAT2; the disease is cancer.